News

Business Exit Planning, Getting a Business Ready for Sale and Building Business Value

Objective Capital Partners’ Trever Acers to Address
North County Estate Planning Council of San Diego on August 1, 2017

San Diego, CA- July 24, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, Trever Acers, will be a panel speaker at the North County Estate Planning Council of San Diego on Tuesday, August 1, 2017. Mr. Acers will address Building and Protecting Business Value to Maximize Realized Dollars and Achieving Transaction Readiness and will be joined by fellow panelists Bob Copeland of Sheppard Mullin and Keith Troutman of Squar Milner. The event will be held at Morgan Run Club & Resort, 5690 Cancha de Golf, Rancho Santa Fe, CA 92091 from 7-9 AM. The guest fee for non-members is $30 and members attend free of charge. (more…)

Important Considerations in the Sale of Your Clients Business

Objective Capital’s Channing Hamlet to present on

July 6, 2017 at Southern California Institute

San Diego, CA- June 26, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, Channing Hamlet, will be a panel speaker as part of Southern California Institute’s (SCI) Thursday Insights on July 6, 2017. Greg Banner of Asset Preservation Strategies, Inc.will join Mr. Hamlet in presenting Important Considerations in the Sale of Your Clients Business. In this session, Greg and Channing will cover a number of core concepts that advisors can use to advise clients at this critical juncture in their personal and business life.  Specifically, they will discuss methods to maximize sale price, assess the sale for fit with client’s objectives, and methods to maximize after-tax cash. (more…)

Objective Capital’s Dr. David Crean to Address Entrepreneurs on Due Diligence Issues

San Diego Startup Week — June 19th – 23rd, 2017

San Diego, CA- June 19, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle-market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will be a panel speaker as part of San Diego Startup Week on June 19-23, 2017 in San Diego, CA. Dr. Crean will address issues to consider on due diligence from an investment banker’s perspective on June 21, 2017. He will be joined by fellow panelists Jeremy Glaser, Attorney and Partner at Mintz Levin, Brent Grenado, General Partner at Sway Ventures, Patrick Henry, CEO at Quest Fusion, and Walt Tendler, CFO at Mission Venture. (more…)

Objective Capital’s Dr. David Crean to Judge Life Sciences Company Pitches at Start-Up Stadium 2017

Start-up and Emerging Companies to Present at BIO2017

San Diego, CA- June 12, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle-market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will serve as a Judge for company finalists during live presentations as part of BIO 2017 Start-Up Stadium on June 20-22, 2017 in San Diego, CA. As the world’s largest biotechnology event, the BIO International Convention provides several specialized opportunities geared towards start-up and emerging companies. The Start-Up Stadium was designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, and BIO attendees. (more…)

The Math Behind the Aftermath Driving a Private-Public Merger Transaction: Mast Therapeutics and Savara

Objective Capital’s Dr. David Crean to Moderate M&A

Panel Discussion for ACG San Diego on June 20, 2017

San Diego, CA- June 6, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will serve as Moderator for ACG San Diego’s Hot Topics in Life Sciences M&A, June 20, 2017 at Lomas Santa Fe Country Club, Solana Beach, CA from 7-9 AM.

(more…)

Objective Capital’s Dr. David Crean to Address International Bar Association’s 5th Annual World Life Sciences Conference in San Diego, CA

Panel Discussion on Life Sciences Transactions, Research Collaborations, and Licensing Models to be presented on June 17, 2017

San Diego, CA- May 31, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will serve as a panel member and address legal professionals at the 5th Annual World Life Sciences Conference, June 16–17, 2017 at the Westin San Diego Gaslamp Quarter, San Diego, CA. The conference is presented by the International Bar Association (IBA), a global voice for the legal profession. The event will feature dynamic roundtable sessions covering the hottest topics and the latest developments from across the different sectors of the Life Science Industry. (more…)

Global Health Solutions Retains Objective Capital Partners As Exclusive Advisor for Acquiring Strategic Partnerships

San Diego, CA, May 15, 2017 Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, has announced that it has been retained as exclusive advisor to Global Health Solutions, LLC, to assist the company in exploring strategic partnerships and licensing agreements for its diverse product portfolio and pipeline for wound care, infection, and skin care. The priority focus will be on seeking best in class commercialization partners for the Company’s 510K FDA-cleared Hexagen™ Wound Dressing, which addresses the pressing need for effective solutions in the chronic and advanced wound market(s).  Additional assets to be partnered include the FiltreX™ Adhesive Dressing and pipeline assets in dermatology, infection control, biologics, and aesthetics. (more…)

Objective Capital Partners Announced as Finalist for Boutique Investment Banking Firm of the Year

San Diego, CA, May 9, 2017 Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, has been announced as a finalist for Boutique Investment Banking Firm of the Year as part of the 9th Annual International M&A Advisor Awards. The M&A Advisor also recognized Objective Capital Partners as finalists in categories for Consumer Discretionary Deal of the Year and Corporate Strategic Deal of the Year ($100mm-250mm).  This is the third year in a row that Objective Capital Partners has been nominated by The M&A Advisor as an award finalist. (more…)

A Roundtable for Life Science Executives: Private Capital Raising

Join CohnReznick, Objective Capital Partners, Wilson Sonsini and an Exclusive Group of Life Science Executives for Engaging Discussion on May 17

San Diego, CA- April 18, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that they have teamed up with CohnReznick and Wilson Sonsini Goodrich & Rosati  to sponsor a  Roundtable discussion on Private Capital Raising for Life Science Companies on Wednesday, May 17, 2017.  The Roundtable discussion will take place from 7:30-9:00 am at Barney & Barney in San Diego, CA.  (more…)

ACG San Diego Private Capital Expo: Healthcare

Objective Capital’s David H. Crean to Lead Discussion on Healthcare Topics at March 23rd Event 

San Diego, CA- March 10, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors and Head of its Life Sciences and Healthcare practice, will lead a group of expert panelists at San Diego’s Association of Corporate Growth (ACG) 7th Annual Private Capital Expo on March 23, 2017 from 5:00-8:00 PM. The panel will address Overall Valuation & Activity Levels in Private Capital Markets as part of a breakout session on Healthcare and Life sciences. Additional panel discussions will explore activity in three other dynamic business sectors including Software & Technology, Action Sports, and Industrial & Manufacturing. (more…)